Antineutrophil cytoplasmic antibody-positive digital necrosis in a patient with limited systemic sclerosis

Journal of Rheumatology

Volumn 37, Issue 1, 2010, Pages 214-215

  Wong, Maida ^a   Ranganath, Veena K ^a   Clements, Philip J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CELECOXIB; CYCLOPHOSPHAMIDE; HEPARIN; HYDROXYCHLOROQUINE; LANSOPRAZOLE; LIDOCAINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOPEROXIDASE; NARCOTIC AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; NIFEDIPINE; PROSTACYCLIN; RHEUMATOID FACTOR; SILDENAFIL;

ADULT; AMPUTATION; ARTHRALGIA; BLISTER; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FINGER MALFORMATION; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HYPERBARIC OXYGEN; LEG EDEMA; LETTER; LEUKOCYTE COUNT; LUNG FUNCTION TEST; MYALGIA; NECROSIS; PARESTHESIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RASH; RAYNAUD PHENOMENON; SKIN BIOPSY; SKIN TINGLING; SMALL VESSEL VASCULITIS; SYSTEMIC SCLEROSIS; TREATMENT DURATION;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; NECROSIS; SCLERODERMA, LIMITED; TOES;

EID: 73649123506     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090154     Document Type: Letter

References (10)

1. Charles C, Clements P. Systemic sclerosis: hypothesis-driven treatment strategies. Lancet 2006;367:1683-91.
2. Herrick A, Oogarah P, Freemont A, Marcuson R, Haeney M, Jayson M. Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation. Ann Rheum Dis 1994;53:323-6.
3. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994;21:864-70.
4. Herrera-Esparza R, Aguilar JL, Saucedo A, González I, López-Robles E, Avalos-Díaz E. Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum. J Eur Acad Dermatol Venereol 2005;19:617-20.
5. Rho Y, Choi S, Lee Y, Ji J, Song G. Scleroderma associated with ANCA-associated vasculitis. Rheumatol Int 2006;26:465-8.
6. Locke I, Worrall J, Leaker B, Black C, Cambridge G. Autoantibodies to myeloperoxidase in systemic sclerosis. J Rheumatol 1997;24:86-9.
7. Cheung G, Chew G, Wyndha R, Peters M, Riminton S. Myeloperoxidase- antineutrophil cytoplasmic antibody seroconversion and fulminant vasculitis in Scl-70-positive scleroderma. Intern Med J 2007;37:205-7.
8. Maes B, Van Mieghem A, Messiaen T, Kuypers D, Van Damme B, Vanrenterghem Y. Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type. Am J Kidney Dis 2000;36:E16.
9. Hiromura K, Nojima Y, Kitahara T, Ueki K, Maezawa A, Kawai H, et al. Four cases of anti-myeloperoxidase antibody-related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis. Clin Nephrol 2000;53:384-9.
10. Casari S, Haeney M, Farrand S, Herrick A. Antineutrophil cytoplasmic antibodies; a "red flag" in patients with systemic sclerosis. J Rheumatol 2002;29:2666-7.